Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE012 (BRA) (Dr. Kowalski)
· consented 2022-06-20
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-07-07 (study day 2); relationship: not assessed
moderate
assessed
2026-08-18
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-07-14 (study day 9); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-07-22 (study day 17); relationship: N
severe
serious
assessed
2026-08-18
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-07-27 (study day 22); relationship: not assessed; serious criteria: hospitalization
severe
assessed
2026-08-18
Grade 3 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-08-01 (study day 27); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.